I've Tried Every Antidepressant: What Are My Options?

If you've cycled through two, three, or five antidepressants and still feel like a worse version of yourself, you are not failing treatment. You are running into a real, well-documented limit of how primary care prescribes for depression. The clinical term for this is treatment-resistant depression, and it applies to roughly one in three people who try SSRIs. The fact that it has a name should tell you something: you are not the exception. The system is.

The first thing worth understanding is why SSRIs miss for so many people. Standard antidepressants work primarily on serotonin, and they take four to eight weeks to do anything noticeable. For some forms of depression, especially depression layered on top of trauma, chronic stress, or significant life disruption, the serotonin lever isn't the right one to pull. The medication isn't broken. It's just being asked to solve a problem it wasn't built for.

Ketamine and Spravato are the most studied of the alternatives. Ketamine works on the glutamate system instead of serotonin, and it tends to act fast, sometimes within hours. In published studies, response rates for ketamine and Spravato in treatment-resistant depression generally fall in the 50 to 70 percent range, the FDA-approved nasal spray version. Response is not the same as cure, and most people need maintenance, but the speed and the response rate are both significantly better than another SSRI trial.

TMS, or transcranial magnetic stimulation, is the non-medication option most people have never heard of. A magnetic coil targets a specific region of the prefrontal cortex over a course of sessions. It is FDA-cleared for depression, OCD, and several other indications. It does not require anesthesia, you drive yourself home, and there are no medication side effects. Standard protocols run five days a week for six weeks. Newer accelerated protocols, sometimes called SAINT, compress that into roughly a week. Insurance coverage for TMS has improved substantially in the last few years.

Psilocybin therapy is no longer hypothetical. Oregon and Colorado have licensed, legal frameworks for psilocybin services delivered by trained facilitators. The clinical research, especially out of Johns Hopkins and NYU, shows large effect sizes for depression and end-of-life distress. It is not for everyone, especially anyone with a personal or family history of psychosis, but for the right person it can move things that nothing else has moved.

If your depression is serious enough that getting through the day is a fight, the answer may not be another medication at all. It may be a higher level of care: an intensive outpatient program a few mornings a week, a partial hospitalization program, a multi-day trauma intensive, or a residential stay. People often resist the idea because it sounds dramatic. It isn't. It's the part of the system designed for exactly this situation, and most people who use it wish they had used it sooner.

When you talk to your prescriber about next steps, ask three questions. What is the next-line option you would recommend if this medication doesn't work? What do you think about ketamine, TMS, or a referral to an intensive program? Who do you trust to refer me to for that? A good prescriber will have answers. If you are met with a shrug or another script, that is useful information about whether you have the right person in your corner.

There is no single right next step. There is only the next honest one. If you want a real human to look at where you are and tell you what makes sense for your situation, that is exactly what Navii does.